Skip to main content
TipRanks
Go Ultimate75% OFF

Serina Therapeutics (SER) Q2 2023 Earnings Report

261 Followers

SER Q2 2023 EPS Results

Actual EPS
-$2.47
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$2.43

SER Q2 2023 Revenue Results

Actual Revenue
$9,000
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
-25.00%

Earnings Announcement Details

Quarter
Q2 2023
Date
08/14/2023
Time
After Close
Conference Call
Monday, August 14, 2023
SER Upcoming Earnings

Serina Therapeutics's next earnings date is estimated for November 18, 2026, based on past reporting schedules.

Q2 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

SER Earnings History

SER earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 18, 20262026 (Q3)-0.34-0.31-0.4531.11% (+0.14)―
Aug 13, 20262026 (Q2)-0.47-0.55-0.6616.67% (+0.11)
May 14, 20262026 (Q1)-0.44-0.58-0.49-18.37% (-0.09)
Mar 25, 20262025 (Q4)-0.50-0.31-1.1372.57% (+0.82)
Nov 13, 20252025 (Q3)-0.53-0.450.13-443.51% (-0.58)
Aug 11, 20252025 (Q2)-0.42-0.660.51-228.91% (-1.17)
May 08, 20252025 (Q1)-0.62-0.49-3.3885.51% (+2.89)
Mar 24, 20252024 (Q4)0.42-1.13-3.264.72% (+2.07)
Nov 12, 20242024 (Q3)―0.13-5102.62% (+5.14)
Aug 09, 20242024 (Q2)―0.51-2.47120.70% (+2.99)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed